KRAS and BRAF mutations are not found in the early serous cystadenoma stage [4], but they have been detected in the APSTs and adjacent cystadenoma epithelium in serous cystadenomas associated with small APSTs [5]. The gene discussed is BRAF; the disease is cystadenoma.